Northland Capmk Has Positive Forecast for DocGo Q3 Earnings

DocGo Inc. (NASDAQ:DCGO) – Analysts at Northland Capmk boosted their Q3 2025 earnings per share (EPS) estimates for shares of DocGo in a research note issued to investors on Friday, February 28th. Northland Capmk analyst M. Latimore now expects that the company will post earnings per share of $0.04 for the quarter, up from their prior forecast of $0.03. The consensus estimate for DocGo’s current full-year earnings is $0.25 per share. Northland Capmk also issued estimates for DocGo’s FY2025 earnings at $0.13 EPS.

Several other equities analysts have also recently commented on the stock. Stifel Nicolaus decreased their price target on shares of DocGo from $6.50 to $5.50 and set a “buy” rating for the company in a research report on Friday, February 28th. Deutsche Bank Aktiengesellschaft lowered shares of DocGo from a “buy” rating to a “hold” rating and dropped their price target for the company from $5.00 to $2.85 in a research note on Friday, February 28th. Finally, Needham & Company LLC cut their target price on DocGo from $7.00 to $4.00 and set a “buy” rating on the stock in a research report on Friday, February 28th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat.com, DocGo currently has an average rating of “Moderate Buy” and a consensus target price of $4.89.

DocGo Price Performance

Shares of NASDAQ:DCGO opened at $2.96 on Monday. The firm has a market capitalization of $302.07 million, a PE ratio of 10.57, a price-to-earnings-growth ratio of 14.16 and a beta of 1.00. The firm’s 50-day moving average is $4.56 and its two-hundred day moving average is $4.02. DocGo has a 1 year low of $2.75 and a 1 year high of $5.68.

Insider Activity at DocGo

In other news, General Counsel Ely D. Tendler sold 23,088 shares of the stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $4.44, for a total transaction of $102,510.72. Following the completion of the transaction, the general counsel now directly owns 175,645 shares of the company’s stock, valued at approximately $779,863.80. This represents a 11.62 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. 2.70% of the stock is currently owned by insiders.

Institutional Investors Weigh In On DocGo

Several institutional investors have recently made changes to their positions in DCGO. Jefferies Financial Group Inc. acquired a new position in DocGo during the fourth quarter worth $123,000. Mackenzie Financial Corp purchased a new stake in shares of DocGo in the fourth quarter valued at $579,000. Squarepoint Ops LLC increased its stake in shares of DocGo by 65.5% during the 4th quarter. Squarepoint Ops LLC now owns 66,260 shares of the company’s stock valued at $281,000 after acquiring an additional 26,221 shares during the last quarter. State of Wyoming increased its position in DocGo by 55.1% during the fourth quarter. State of Wyoming now owns 159,033 shares of the company’s stock worth $674,000 after purchasing an additional 56,500 shares during the last quarter. Finally, ProShare Advisors LLC raised its position in shares of DocGo by 49.0% in the 4th quarter. ProShare Advisors LLC now owns 28,641 shares of the company’s stock worth $121,000 after buying an additional 9,425 shares during the period. 56.44% of the stock is currently owned by hedge funds and other institutional investors.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.